Processa Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Prepaid Expense and Other Assets of $270.40 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $156.96K.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $113.44K.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$144.42K, a 1535.47% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $55.61K, a 39.64% increase year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$834.65K, a 181.00% decline from fiscal 2024.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.03M.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$956.83K.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$210.55K, a 120.68% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 27 month | Increase (Decrease) in Prepaid Expense and Other Assets 30 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $156.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $270.40K 10-Q · filed 2026-08-14 | $125.98K derived: sum of 3 quarters · filed 2026-08-14 | $181.59K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $113.44K 10-Q · filed 2026-05-07 | -$30.98K derived: sum of 2 quarters · filed 2026-05-07 | $24.63K derived: sum of 3 quarters · filed 2026-05-07 | -$591.21K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$144.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$88.82K derived: sum of 2 quarters · filed 2026-03-18 | -$704.66K derived: sum of 3 quarters · filed 2026-08-14 | -$834.65K 10-K · filed 2026-03-18 | |||
| 2025-09-30 | $55.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$560.23K derived: sum of 2 quarters · filed 2026-08-14 | -$690.23K 10-Q · filed 2025-11-06 | -$680.17K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$615.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$745.83K 10-Q · filed 2026-08-14 | -$735.77K derived: sum of 3 quarters · filed 2026-08-14 | -$695.95K derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$130.00K 10-Q · filed 2026-05-07 | -$119.93K derived: sum of 2 quarters · filed 2026-05-07 | -$80.11K derived: sum of 3 quarters · filed 2026-05-07 | $969.11K derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $10.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $49.88K derived: sum of 2 quarters · filed 2026-03-18 | $1.10M derived: sum of 3 quarters · filed 2026-03-18 | $1.03M 10-K · filed 2026-03-18 | |||
| 2024-09-30 | $39.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.09M derived: sum of 2 quarters · filed 2025-11-06 | $1.02M 10-Q · filed 2025-11-06 | $899.88K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $980.55K 10-Q · filed 2025-08-07 | $860.06K derived: sum of 3 quarters · filed 2025-08-07 | $686.70K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | -$68.67K 10-Q · filed 2025-05-08 | -$189.16K derived: sum of 2 quarters · filed 2025-05-08 | -$362.51K derived: sum of 3 quarters · filed 2025-05-08 | -$619.88K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$120.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$293.85K derived: sum of 2 quarters · filed 2025-03-20 | -$551.22K derived: sum of 3 quarters · filed 2025-03-20 | -$956.83K 10-K · filed 2025-03-20 | |||
| 2023-09-30 | -$173.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$430.73K derived: sum of 2 quarters · filed 2024-10-30 | -$836.34K 10-Q · filed 2024-10-30 | -$747.82K derived: sum of 4 quarters · filed 2024-10-30 | |||
| 2023-06-30 | -$257.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$662.98K 10-Q · filed 2024-08-13 | -$574.46K derived: sum of 3 quarters · filed 2024-08-13 | -$601.48K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$405.62K 10-Q · filed 2024-05-10 | -$317.09K derived: sum of 2 quarters · filed 2024-05-10 | -$344.11K derived: sum of 3 quarters · filed 2024-05-10 | -$399.45K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | $88.53K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $61.50K derived: sum of 2 quarters · filed 2024-03-29 | $6.17K derived: sum of 3 quarters · filed 2024-03-29 | -$210.55K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$27.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$82.36K derived: sum of 2 quarters · filed 2023-11-13 | -$299.07K 10-Q · filed 2023-11-13 | $54.60K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$55.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$272.05K 10-Q · filed 2023-08-10 | $81.63K derived: sum of 3 quarters · filed 2023-08-10 | -$130.85K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$216.72K 10-Q · filed 2023-05-15 | $136.96K derived: sum of 2 quarters · filed 2023-05-15 | -$75.52K derived: sum of 3 quarters · filed 2023-05-15 | $244.24K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $353.68K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $141.20K derived: sum of 2 quarters · filed 2023-03-30 | $460.96K derived: sum of 3 quarters · filed 2023-03-30 | $1.02M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$212.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $107.28K derived: sum of 2 quarters · filed 2022-11-08 | $664.42K 10-Q · filed 2022-11-08 | $1.18M derived: sum of 4 quarters · filed 2022-11-08 | |||
| 2021-06-30 | $319.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $876.90K 10-Q · filed 2022-08-11 | $1.39M derived: sum of 3 quarters · filed 2022-08-11 | $1.33M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $557.14K 10-Q · filed 2022-05-12 | $1.07M derived: sum of 2 quarters · filed 2022-05-12 | $1.01M derived: sum of 3 quarters · filed 2022-05-12 | $925.59K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $511.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $457.03K derived: sum of 2 quarters · filed 2022-03-30 | $368.46K derived: sum of 3 quarters · filed 2022-03-30 | $239.10K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | -$54.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$143.40K derived: sum of 2 quarters · filed 2021-11-12 | -$272.75K 10-Q · filed 2021-11-12 | -$177.43K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$88.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$217.92K 10-Q · filed 2021-08-12 | -$122.60K derived: sum of 3 quarters · filed 2021-08-12 | -$170.24K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$129.35K 10-Q · filed 2021-05-13 | -$34.03K derived: sum of 2 quarters · filed 2021-05-13 | -$81.67K derived: sum of 3 quarters · filed 2021-05-13 | -$60.95K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $95.33K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $47.68K derived: sum of 2 quarters · filed 2021-03-25 | $68.41K derived: sum of 3 quarters · filed 2021-03-25 | $57.77K 10-K · filed 2021-03-25 | -$57.77K 10-K · filed 2020-03-06 | ||
| 2019-09-30 | -$47.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$26.92K derived: sum of 2 quarters · filed 2020-11-12 | -$37.55K 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $20.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $10.09K 10-Q · filed 2020-08-05 | |||||
| 2019-03-31 | -$10.63K 10-Q · filed 2020-05-15 | ||||||
| 2018-12-31 | -$216.39K 10-K · filed 2020-03-06 | ||||||
| 2013-09-30 | -$31.63K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | -$30.22K 10-Q · filed 2013-11-08 | -$80.59K 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | $1.41K 10-Q/A · filed 2013-09-06 | -$48.96K 10-Q/A · filed 2013-09-06 | |||||
| 2012-09-30 | -$96.35K 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |